Trial Profile
Comparative Study of the Levofloxacin-Based and Clarithromycin-Based Triple Therapy in First-Line Treatment for Helicobacter Pylori Eradication and Change of Gut Flora and Drug Susceptibility Before and After Treatment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Levofloxacin (Primary) ; Amoxicillin; Clarithromycin; Lansoprazole
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- 14 Jun 2010 Status changed from recruiting to completed.
- 03 May 2010 Results published in Gut.
- 05 Jan 2009 New trial record.